Dare Bioscience最新数据显示,一项临床研究中因阴道异味而退出的参与者比例降至12%,这一数字较2025年7月记录的17%下降了5个百分点。这一变化反映了公司在产品耐受性方面的潜在改善。
Dare Bioscience最新数据显示,一项临床研究中因阴道异味而退出的参与者比例降至12%,这一数字较2025年7月记录的17%下降了5个百分点。这一变化反映了公司在产品耐受性方面的潜在改善。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.